SGLT-2 Inhibitors Increase Retinal Vein Occlusion Risk in Diabetics, Study Finds
SGLT2 inhibitors are associated with an increased risk of RVO when compared with other glucose lowering drugs.;
Advertisement
Type 2 Diabetes, also called as Adult Onset Diabetes, has emerged as a major global health concern over the past few decades. It is a chronic condition that affects the way the body processes blood sugar.
With type 2 diabetes, the body either doesn't produce enough insulin, or it resists insulin.
Symptoms include increased thirst, frequent urination, hunger, fatigue and blurred vision. In some cases, there may be no symptoms. Sodium-glucose cotransporter-2 (SGLT2) inhibitors are often prescribed along with metformin for patients with Type 2 Diabetes.
Patients with type 2 diabetes are medically compromised and are susceptible to a number of complications. One of the most commonly noted complication is retinal Vein Occlusion (RVO). Retinal vein occlusion is a blockage of the small veins that carry blood away from the retina. With this background, a team of researchers from South Korea, led by Min-Kyung Lee, carried out a study to assess the association between use of sodium-glucose cotransporter-2 (SGLT2) inhibitors and retinal vein occlusion (RVO) using data from the National Health Insurance Service in South Korea.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.